MDxHealth Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . MDxHealth SA ADR
MDXH Stock  USD 3.65  0.05  1.35%   
MDxHealth's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing MDxHealth's valuation are provided below:
Gross Profit
66.5 M
Profit Margin
(0.30)
Market Capitalization
190 M
Enterprise Value Revenue
2.3862
Revenue
103.1 M
We have found one hundred twenty available fundamental ratios for MDxHealth, which can be analyzed and compared to other ratios and to its peers in the industry. Traders should compare all of MDxHealth last-minute fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The MDxHealth's current Market Cap is estimated to increase to about 118.4 M. The MDxHealth's current Enterprise Value is estimated to increase to about 114.3 M

MDxHealth Total Revenue

108.73 Million

Check MDxHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MDxHealth's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.7 M, Interest Expense of 9.2 M or Selling General Administrative of 66.4 M, as well as many indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0 or PTB Ratio of 7.34. MDxHealth financial statements analysis is a perfect complement when working with MDxHealth Valuation or Volatility modules.
  
Build AI portfolio with MDxHealth Stock
Check out the analysis of MDxHealth Correlation against competitors.

MDxHealth Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets190 M180.9 M75.4 M
Slightly volatile
Short and Long Term Debt Total72.5 M69.1 M19.5 M
Slightly volatile
Other Current Liabilities39.8 M37.9 M9.6 M
Slightly volatile
Total Current Liabilities51.5 M49.1 M17.1 M
Slightly volatile
Total Stockholder Equity21.8 M13.4 M24.6 M
Pretty Stable
Property Plant And Equipment Net15.7 M14.9 M5 M
Slightly volatile
Cash28.5 M53.8 M26 M
Slightly volatile
Non Current Assets Total109.2 M104 M34.5 M
Slightly volatile
Cash And Short Term Investments28.5 M53.8 M26 M
Slightly volatile
Net Receivables8.6 M16.7 M9.5 M
Slightly volatile
Common Stock Shares Outstanding58.8 M56 M15.4 M
Slightly volatile
Liabilities And Stockholders Equity190 M180.9 M75.4 M
Slightly volatile
Non Current Liabilities Total120.5 M114.8 M33.9 M
Slightly volatile
Other Current Assets1.2 M1.5 M1.3 M
Very volatile
Other Stockholder Equity205.6 M195.8 M110.1 M
Slightly volatile
Total Liabilities172.1 M163.9 M50.8 M
Slightly volatile
Total Current Assets39.3 M76.9 M38.5 M
Slightly volatile
Short Term Debt1.3 M1.9 M1.4 M
Slightly volatile
Intangible Assets49 M46.7 M17.6 M
Slightly volatile
Common Stock259.2 M246.9 M97.6 M
Slightly volatile
Accounts Payable5.7 M9.2 M5.9 M
Slightly volatile
Short Term Investments66 K126.5 K59.8 K
Slightly volatile
Inventory4.7 M4.4 M1.9 M
Slightly volatile
Other Liabilities64.6 M61.6 M17.8 M
Slightly volatile
Net Invested Capital49.2 M76.1 M46.3 M
Slightly volatile
Non Current Liabilities Other25.4 M47.7 M14.1 M
Slightly volatile
Net Working Capital19.7 M21.8 M24.8 M
Pretty Stable
Property Plant Equipment9.5 M9.1 M4.5 M
Slightly volatile
Capital Lease Obligations10.6 M10.1 M2.9 M
Slightly volatile
Short and Long Term Debt277 K291.6 K664.6 K
Slightly volatile
Capital Stock132.6 M246.9 M97.3 M
Slightly volatile
Property Plant And Equipment Gross16.3 M26.7 M12.5 M
Slightly volatile

MDxHealth Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization9.7 M9.2 M3.4 M
Slightly volatile
Interest Expense9.2 M8.8 M2.3 M
Slightly volatile
Selling General Administrative66.4 M63.2 M18.9 M
Slightly volatile
Total Revenue108.7 M103.6 M35.7 M
Slightly volatile
Other Operating Expenses138.6 M132 M57.8 M
Slightly volatile
Research Development5.5 M9.5 M4.9 M
Slightly volatile
Cost Of Revenue42.2 M40.1 M14.6 M
Slightly volatile
Total Operating Expenses96.4 M91.8 M43.2 M
Slightly volatile
Selling And Marketing Expenses10.3 M7.4 M8.5 M
Slightly volatile
Reconciled Depreciation4.8 M9.2 M3.7 M
Slightly volatile

MDxHealth Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow26.4 M25.7 M22.4 M
Slightly volatile
Depreciation9.7 M9.2 M3.4 M
Slightly volatile
Capital Expenditures1.9 M2.5 M2 M
Slightly volatile
Total Cash From Financing Activities53.9 M51.3 M27.5 M
Slightly volatile
End Period Cash Flow28.6 M53.8 M26.1 M
Slightly volatile
Stock Based Compensation2.1 M2 M903 K
Slightly volatile
Change To Netincome4 M7.6 M3.1 M
Slightly volatile
Issuance Of Capital Stock40.1 M46.8 M40.1 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.41.473.666
Slightly volatile
PTB Ratio7.346.994.8628
Slightly volatile
Days Sales Outstanding64.3567.74176
Slightly volatile
Book Value Per Share0.330.355.8269
Slightly volatile
Average Payables2.7 M2.2 M1.9 M
Slightly volatile
Stock Based Compensation To Revenue0.02090.0220.0415
Slightly volatile
Capex To Depreciation0.290.311.2853
Slightly volatile
PB Ratio7.346.994.8628
Slightly volatile
EV To Sales1.351.292.5826
Pretty Stable
Inventory Turnover10.2610.389.4895
Pretty Stable
Days Of Inventory On Hand40.3436.4147.495
Pretty Stable
Payables Turnover4.123.931.9949
Slightly volatile
Sales General And Administrative To Revenue0.880.70.7164
Pretty Stable
Average Inventory83.4 K132.3 K127.3 K
Slightly volatile
Capex To Revenue0.02620.02760.1262
Slightly volatile
Cash Per Share1.051.113.9433
Slightly volatile
Days Payables Outstanding91.496.211.3 K
Slightly volatile
Income Quality0.990.860.8988
Slightly volatile
Intangibles To Total Assets0.460.440.245
Slightly volatile
Current Ratio1.711.83.3262
Slightly volatile
Receivables Turnover4.07.133.1661
Slightly volatile
Shareholders Equity Per Share0.330.355.8269
Slightly volatile
Debt To Equity3.823.641.489
Slightly volatile
Capex Per Share0.04850.0510.3542
Slightly volatile
Average Receivables1.4 M2.7 M2.7 M
Pretty Stable
Revenue Per Share3.812.133.1753
Very volatile
Interest Debt Per Share0.651.250.9086
Slightly volatile
Debt To Assets0.360.340.169
Slightly volatile
Operating Cycle109114220
Slightly volatile
Price Book Value Ratio7.346.994.8628
Slightly volatile
Days Of Payables Outstanding91.496.211.3 K
Slightly volatile
Ebt Per Ebit0.841.371.0978
Slightly volatile
Company Equity Multiplier10.029.544.7912
Slightly volatile
Long Term Debt To Capitalization0.730.70.3119
Slightly volatile
Total Debt To Capitalization0.760.720.3222
Slightly volatile
Debt Equity Ratio3.823.641.489
Slightly volatile
Quick Ratio1.611.73.2256
Slightly volatile
Net Income Per E B T0.80.910.9793
Slightly volatile
Cash Ratio1.21.262.1606
Slightly volatile
Days Of Inventory Outstanding40.3436.4147.495
Pretty Stable
Days Of Sales Outstanding64.3567.74176
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.91.01.102
Pretty Stable
Price To Book Ratio7.346.994.8628
Slightly volatile
Fixed Asset Turnover5.246.247.7018
Very volatile
Debt Ratio0.360.340.169
Slightly volatile
Price Sales Ratio1.41.473.666
Slightly volatile
Asset Turnover0.540.520.3905
Slightly volatile
Price Fair Value7.346.994.8628
Slightly volatile

MDxHealth Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap118.4 M117.4 M114 M
Slightly volatile

MDxHealth Fundamental Market Drivers

MDxHealth Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MDxHealth Financial Statements

Investors use fundamental indicators, such as MDxHealth's revenue or net income, to determine how well the company is positioned to perform in the future. Although MDxHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue542.8 K515.7 K
Total Revenue103.6 M108.7 M
Cost Of Revenue40.1 M42.2 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.70  0.88 
Research And Ddevelopement To Revenue 0.12  0.13 
Capex To Revenue 0.03  0.03 
Revenue Per Share 2.13  3.81 
Ebit Per Revenue(0.25)(0.26)

Currently Active Assets on Macroaxis

WDWalker Dunlop
GMGeneral Motors
GMGeneral Motors
BACBank of America
SSentinelOne
When determining whether MDxHealth SA ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MDxHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mdxhealth Sa Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mdxhealth Sa Adr Stock:
How To Invest In MDxHealth
Details
Is MDxHealth Stock a good investment?
Details
What is MDxHealth's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of MDxHealth Correlation against competitors.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is there potential for Biotechnology market expansion? Will MDxHealth introduce new products? Factors like these will boost the valuation of MDxHealth. Expected growth trajectory for MDxHealth significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about MDxHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.52)
Revenue Per Share
2.095
Quarterly Revenue Growth
0.177
Return On Assets
(0.06)
Return On Equity
(7.20)
The market value of MDxHealth SA ADR is measured differently than its book value, which is the value of MDxHealth that is recorded on the company's balance sheet. Investors also form their own opinion of MDxHealth's value that differs from its market value or its book value, called intrinsic value, which is MDxHealth's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because MDxHealth's market value can be influenced by many factors that don't directly affect MDxHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Understanding that MDxHealth's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether MDxHealth represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, MDxHealth's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY